3 completed, 2 not yet recruiting, 2 terminated, 1 recruiting. 3 Not applicable, 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 4 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Aspergillosis Invasive: new trials by email Literature Review of Aspergillosis Invasive trials Research Report on Aspergillosis Invasive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liposomal Amphotericin B in Invasive Aspergillosis With Hepatic Dysfunction LIposomal amphotericin B (L-AmB) treatment - Aspergillosis Invasive | Not applicable | Not yet recruiting | Southeast University, China | 40 | 2025-12-20 | 2026-01-13 |
| Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI) Beta-1,3/1,6-D-Glucan - Candidemia, Aspergillosis Invasive | Completed | Central Hospital, Nancy, France | 280 | 2024-12-17 | 2025-12-09 | |
| Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm Individualization of first voriconazole maintenance doses - Aspergillosis Invasive, Fungal Infection | Phase 4 | Not yet recruiting | University Hospital, Grenoble | 30 | 2024-10-01 | 2024-09-03 |
| Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children Theraputic drug monitoring, Isavuconazole - Aspergillosis Invasive, Mucormycosis | Not applicable | Recruiting | Shanghai Children's Medical Center | 200 | 2024-06-06 | 2024-12-13 |
| Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis Isavuconazonium Injection [Cresemba], Placebo - Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive | Phase 3 | Terminated | Jeffrey Jenks, MD, MPH | 8 | 2021-03-16 | 2022-11-25 |
| Invasive Pulmonary Aspergillosis Complicating Influenza Infection Influenza With Pneumonia, Aspergillosis Invasive | Completed | Universitaire Ziekenhuizen KU Leuven | 298 | 2018-01-20 | 2021-07-30 | |
| CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels Voriconazole genotype-specific dosing, Standard of Care - Aspergillosis Invasive, Fungal Infection | Phase 4 | Completed | University Health Network, Toronto | 30 | 2018-01-10 | 2020-11-03 |
| Novel Biomarkers for Invasive Aspergillosis blood sample - Aspergillosis Invasive | Not applicable | Terminated | Universitaire Ziekenhuizen KU Leuven | 226 | 2017-01-01 | 2024-07-03 |
Mycoses (2) · Candidemia (1) · Hematologic Neoplasms (1) · Liver Diseases (1) · Mucormycosis (1) · Pneumonia (1) · Pneumonia, Pneumocystis (1)
Bacterial Infections and Mycoses (4) · Infections (4) · Mycoses (2) · Candidiasis (1) · Candidiasis, Invasive (1) · Digestive System Diseases (1) · Fungemia (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Inflammation (1) · Invasive Fungal Infections (1) · Lung Diseases (1) · Lung Diseases, Fungal (1) · Neoplasms (1) · Neoplasms by Site (1)
isavuconazole (2) · Blood Specimen Collection (1) · Standard of Care (1) · Therapeutics (1) · liposomal amphotericin B (1)
Universitaire Ziekenhuizen KU Leuven (2) · Central Hospital, Nancy, France (1) · Jeffrey Jenks, MD, MPH (1) · Shanghai Children's Medical Center (1) · Southeast University, China (1) · University Health Network, Toronto (1) · University Hospital, Grenoble (1)
Belgium (2) · France (2) · Canada (1) · China (1) · United States (1)
Gautier-Veyret Elodie (1) · George Thompson, MD (1) · Jeffrey Jenks, MD, MPH (1) · Joost Wauters, Phd (1) · Juan Wu, PhD (1) · Marisa Battistella, PharmD (1) · Martin Hoenigl, MD (1)